Guggenheim Downgrades Cidara Therapeutics (CDTX) to Neutral Nov 17, 2025 01:22PM
Morgan Stanley Downgrades Cidara Therapeutics (CDTX) to Equalweight Nov 17, 2025 06:22AM
JPMorgan Downgrades Cidara Therapeutics (CDTX) to Neutral Nov 17, 2025 03:19AM
RBC Capital Downgrades Cidara Therapeutics (CDTX) to Sector Perform Nov 17, 2025 03:17AM
Where can biotech stocks go from here? RBC answers Nov 16, 2025 03:00PM
View Older Stories

Nov 14, 2025 12:13PM Needham Downgrades Cidara Therapeutics (CDTX) to Hold
Nov 14, 2025 10:31AM H.C. Wainwright Downgrades Cidara Therapeutics (CDTX) to Neutral
Nov 14, 2025 10:23AM Increasing unusual call option volume: CDTX UDN CNP EU IVVD XP CWAN SSRM GLNG GLBE AIG AVDX
Nov 14, 2025 06:45AM Merck to acquire Cidara for $9.2 billion to gain influenza drug
Nov 14, 2025 05:44AM Cidara Therapeutics (CDTX) call put ratio 3.4 calls to 1 put
Nov 13, 2025 06:31PM Merck (MRK) Nearing Deal To Buy Cidara Therapeutics- FT
Nov 6, 2025 05:12PM Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c
Oct 24, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Cidara Therapeutics (CDTX)
Oct 23, 2025 08:01AM Cidara presents CD388 influenza data at European conference
Oct 21, 2025 04:06AM Citizens Reiterates Cidara Therapeutics (CDTX) at Market Outperform After CD388 Phase 2 Trial
Oct 16, 2025 03:10AM Morgan Stanley Starts Cidara Therapeutics (CDTX) at Overweight
Oct 10, 2025 06:42AM Cidara Therapeutics (CDTX) PT Raised to $150 at H.C. Wainwright
Oct 10, 2025 02:47AM JPMorgan Starts Cidara Therapeutics (CDTX) at Overweight
Oct 3, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Cidara Therapeutics (CDTX)
Oct 3, 2025 04:06AM Cidara Therapeutics (CDTX) PT Raised to $173 at Citizens
Oct 2, 2025 04:01PM Cidara receives up to $339 million BARDA award for influenza drug development
Sep 25, 2025 07:07AM Cidara Therapeutics (CDTX) PT Raised to $167 at Guggenheim
Sep 25, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Cidara Therapeutics (CDTX)
Sep 23, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)
Sep 22, 2025 07:15AM Cidara Therapeutics (CDTX) PT Raised to $123 at WBB Securities
Sep 17, 2025 08:02AM Cidara Therapeutics Presents Data on CD388 from its Phase 2b NAVIGATE Trial and Preclinical Studies Against H5N1 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Aug 19, 2025 02:12PM Cidara Therapeutics (CDTX) PT Raised to $66 at Citizens JMP
Aug 8, 2025 08:29AM Cidara Therapeutics (CDTX) PT Raised to $70 at Guggenheim
Aug 8, 2025 04:18AM Cidara Therapeutics (CDTX) PT Raised to $66 at Citizens JMP
Aug 6, 2025 02:07PM Cidara Therapeutics (CDTX) PT Raised to $115 at RBC Capital
Jul 9, 2025 08:22AM Cidara Therapeutics (CDTX) PT Raised to $69 at Guggenheim
Jun 30, 2025 06:34AM Citizens JMP Reiterates Market Outperform Rating on Cidara Therapeutics (CDTX)
Jun 24, 2025 09:13AM Cidara Therapeutics (CDTX) PT Raised at RBC Capital; 'Would Be Buyers Into Strength'
Jun 24, 2025 07:06AM Cidara Therapeutics (CDTX) PT Raised to $68 at Guggenheim
Jun 24, 2025 06:48AM Cidara Therapeutics (CDTX) PT Raised to $53 at H.C. Wainwright
Jun 23, 2025 04:16PM Cidara Therapeutics (CDTX) Announces Proposed $250M Share Offering
Jun 23, 2025 07:00AM Cidara Therapeutics (CDTX) Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
Jun 18, 2025 06:41AM H.C. Wainwright Assumes Cidara Therapeutics (CDTX) at Buy
Jun 10, 2025 06:45AM Cantor Fitzgerald Reiterates Overweight Rating on Cidara Therapeutics (CDTX)
Jun 5, 2025 04:05AM Citizens JMP Reiterates Market Outperform Rating on Cidara Therapeutics (CDTX)
Jun 4, 2025 07:12AM Cidara Therapeutics (CDTX) PT Raised to $36 at Needham
Jun 2, 2025 04:04AM Citizens JMP Reiterates Market Outperform Rating on Cidara Therapeutics (CDTX)
May 27, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Cidara Therapeutics (CDTX)
May 16, 2025 06:00AM Cidara Therapeutics (CDTX) July 17.50 puts and July 20 calls active
May 9, 2025 04:30AM Cidara Therapeutics (CDTX) PT Raised to $47 at Citizens JMP
May 1, 2025 08:00AM Cidara Therapeutics (CDTX) Appoints Nicole Davarpanah as Chief Medical Officer
Apr 29, 2025 04:17AM Citizens JMP Reiterates Market Outperform Rating on Cidara Therapeutics (CDTX)
Apr 16, 2025 08:02AM Phathom Pharmaceuticals Inc. (PHAT) Appoints Ted Schroeder to its Board of Directors
Apr 15, 2025 06:59AM Cantor Fitzgerald Reiterates Overweight Rating on Cidara Therapeutics (CDTX)
Mar 12, 2025 03:36AM Citizens JMP Starts Cidara Therapeutics (CDTX) at Market Outperform
Mar 10, 2025 06:45AM Cidara Therapeutics (CDTX) PT Raised to $35 at H.C. Wainwright
Mar 6, 2025 04:53PM Cidara Therapeutics (CDTX) Misses Q4 EPS by 537c
Feb 18, 2025 04:15PM Cidara Therapeutics (CDTX) Appoints Frank Karbe as CFO
Jan 27, 2025 08:47AM Cantor Fitzgerald Assumes Cidara Therapeutics (CDTX) at Overweight
View Older Stories